Ladenburg On Biotech: Starts Achillion, Alnylam, Corcept, Trevana At Buy
February 02, 2017 at 09:21 AM EST
Ladenburg Thalmann’s Christopher S. James initiated coverage of four biotech companies with a Buy rating, given that each has a ...
